2022
DOI: 10.1038/s41467-022-30858-8
|View full text |Cite
|
Sign up to set email alerts
|

NANOG initiates epiblast fate through the coordination of pluripotency genes expression

Abstract: The epiblast is the source of all mammalian embryonic tissues and of pluripotent embryonic stem cells. It differentiates alongside the primitive endoderm in a “salt and pepper” pattern from inner cell mass (ICM) progenitors during the preimplantation stages through the activity of NANOG, GATA6 and the FGF pathway. When and how epiblast lineage specification is initiated is still unclear. Here, we show that the coordinated expression of pluripotency markers defines epiblast identity. Conversely, ICM progenitor … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(20 citation statements)
references
References 108 publications
1
19
0
Order By: Relevance
“…Additionally, a recent paper reports NANOG dependent coordinated expression of pluripotency related gene expression during the 16-to 32-cell stage transition, suggesting EPI specification may actually originate (in part) in primary ICM founders [74]. Whilst not definitive, these collective data at least support an aspect of developmental history underlying ICM cell fate, that is nonetheless potentially subject to regulative and compensatory mechanisms.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…Additionally, a recent paper reports NANOG dependent coordinated expression of pluripotency related gene expression during the 16-to 32-cell stage transition, suggesting EPI specification may actually originate (in part) in primary ICM founders [74]. Whilst not definitive, these collective data at least support an aspect of developmental history underlying ICM cell fate, that is nonetheless potentially subject to regulative and compensatory mechanisms.…”
Section: Discussionmentioning
confidence: 91%
“…Although previously, we reported clonal inhibition of TE cell fate, using microinjected siRNAs specific for Tead4 transcripts, generates excess ICM contribution favouring EPI and biased against PrE formation, respectively [43]; strongly suggesting an extra ∼12 hours of polarity-dependent Hippo-pathway suppression in outer 16-cell stage blastomeres may prime derived secondary ICM founders to preferentially differentiate towards PrE. Additionally, a recent paper reports NANOG dependent coordinated expression of pluripotency related gene expression during the 16-to 32-cell stage transition, suggesting EPI specification may actually originate (in part) in primary ICM founders [74]. Whilst not definitive, these collective data at least support an aspect of developmental history underlying ICM cell fate, that is nonetheless potentially subject to regulative and compensatory mechanisms.…”
Section: Discussionmentioning
confidence: 99%
“…Genes implicated in the literature to correspond with 13 of our cell type annotations are represented in the 3012 cESFW gene set (Cockburn and Rossant 2010; Taubenschmid-Stowers et al 2022; Giuliano G. Stirparo et al 2018; M. Singh et al 2023; Corujo-Simon, A. H. Radley, and Nichols 2023; Liu et al 2022; Zadora et al 2017; Yue et al 2020; Yabe et al 2016; Yang et al 2021). Such genes show specific gene expression in the UMAP embedding (Fig 3E, Fig 5A Fig S3).…”
Section: Resultsmentioning
confidence: 99%
“…Cells in these clusters become specified to alternative fates but may not be committed. For example, PDGFRA has been implicated as a hypoblast marker (Corujo-Simon, A. H. Radley, and Nichols 2023), whereas NANOG has been demonstrated as an epiblast marker (Allègre et al 2022), yet both markers are heterogeneous in Epi/Hyp branching population. Notably the cluster boundaries extend beyond the topological branch point, which may indicate that cells remain plastic and could be respecified.…”
Section: Discussionmentioning
confidence: 99%
“…The exit from naïve pluripotency in vivo is accompanied by a substantial increase in molecular and phenotypic cell heterogeneity. Cellular heterogeneity, in terms of gene expression and morphology, was observed since the formation of the ICM in mouse blastocysts [ 62 , 63 , 64 ]. Similar changes accompany the transition from naïve ESCs to PiCs as well as the generation of other intermediate states of pluripotency, including RSCs [ 3 ] and intermediate epiblast stem cells (IESCs) [ 19 ].…”
Section: Discussionmentioning
confidence: 99%